Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ATXN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
S100A11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR664B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP70 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00094 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
CXorf40A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSPAN4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CETN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DAPK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSD17B11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAPK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATOX1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BRD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GTF2E2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IMPACT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAFG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TADA2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SGPL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on